MedTrace Logo

PASCAL for Tricuspid Regurgitation - a European Registry

NCT05328284 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-04-14

No results posted yet for this study

Summary

This study aims to investigate the safety and efficacy of the PASCAL leaflet repair system in the treatment of tricuspid regurgitation in a commercial use setting including all consecutive patients at the participating Centers in an observational fashion.

Conditions

  • Tricuspid Regurgitation

Interventions

DEVICE

PASCAL leaflet repair system

transcatheter Implantation of one or more PASCAL devices in the tricuspid valve

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2023-05-30
Completion
2024-05-30

Countries

  • Germany
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05328284 on ClinicalTrials.gov